메뉴 건너뛰기




Volumn 70, Issue 4, 2016, Pages 549-552

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer

Author keywords

In situ hybridization; Lethal prostate cancer; long noncoding RNA; Metastatic prostate cancer; SChLAP1

Indexed keywords

BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; SCHLAP1 LONG NONCODING RNA; TUMOR MARKER;

EID: 84951855012     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.12.003     Document Type: Article
Times cited : (109)

References (10)
  • 1
    • 82155186923 scopus 로고    scopus 로고
    • The emergence of lncRNAs in cancer biology
    • [1] Prensner, J.R., Chinnaiyan, A.M., The emergence of lncRNAs in cancer biology. Cancer Discov 1 (2011), 391–407.
    • (2011) Cancer Discov , vol.1 , pp. 391-407
    • Prensner, J.R.1    Chinnaiyan, A.M.2
  • 2
    • 84893596081 scopus 로고    scopus 로고
    • Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution
    • [2] Udager, A.M., Alva, A., Mehra, R., Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution. Cancer J 20 (2014), 29–42.
    • (2014) Cancer J , vol.20 , pp. 29-42
    • Udager, A.M.1    Alva, A.2    Mehra, R.3
  • 3
    • 84925231126 scopus 로고    scopus 로고
    • RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
    • [3] Prensner, J.R., Zhao, S., Erho, N., et al. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol 15 (2014), 1469–1480.
    • (2014) Lancet Oncol , vol.15 , pp. 1469-1480
    • Prensner, J.R.1    Zhao, S.2    Erho, N.3
  • 4
    • 84887122461 scopus 로고    scopus 로고
    • The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
    • [4] Prensner, J.R., Iyer, M.K., Sahu, A., et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 45 (2013), 1392–1398.
    • (2013) Nat Genet , vol.45 , pp. 1392-1398
    • Prensner, J.R.1    Iyer, M.K.2    Sahu, A.3
  • 5
    • 79961202865 scopus 로고    scopus 로고
    • Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lncRNA implicated in disease progression
    • [5] Prensner, J.R., Iyer, M.K., Balbin, O.A., et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lncRNA implicated in disease progression. Nat Biotechnol 29 (2011), 742–749.
    • (2011) Nat Biotechnol , vol.29 , pp. 742-749
    • Prensner, J.R.1    Iyer, M.K.2    Balbin, O.A.3
  • 6
    • 85003318605 scopus 로고    scopus 로고
    • A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer
    • [6] Mehra, R., Shi, Y., Udager, A.M., et al. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia 16 (2014), 1121–1127.
    • (2014) Neoplasia , vol.16 , pp. 1121-1127
    • Mehra, R.1    Shi, Y.2    Udager, A.M.3
  • 7
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • [7] Pound, C.R., Partin, A.W., Eisenberger, M.A., Chan, D.W., Pearson, J.D., Walsh, P.C., Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999), 1591–1597.
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3    Chan, D.W.4    Pearson, J.D.5    Walsh, P.C.6
  • 8
    • 84879690468 scopus 로고    scopus 로고
    • Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
    • [8] Cuzick, J., Yang, Z.H., Fisher, G., et al. Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. Br J Cancer 108 (2013), 2582–2589.
    • (2013) Br J Cancer , vol.108 , pp. 2582-2589
    • Cuzick, J.1    Yang, Z.H.2    Fisher, G.3
  • 9
    • 80054111295 scopus 로고    scopus 로고
    • PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients
    • [9] Lotan, T.L., Gurel, B., Sutcliffe, S., et al. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res 17 (2011), 6563–6573.
    • (2011) Clin Cancer Res , vol.17 , pp. 6563-6573
    • Lotan, T.L.1    Gurel, B.2    Sutcliffe, S.3
  • 10
    • 84924225344 scopus 로고    scopus 로고
    • Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
    • [10] Bottcher, R., Hoogland, A.M., Dits, N., et al. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer. Oncotarget 6 (2015), 4036–4050.
    • (2015) Oncotarget , vol.6 , pp. 4036-4050
    • Bottcher, R.1    Hoogland, A.M.2    Dits, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.